Outcomes of early discharge in patients with myocardial infarction

Study the outcomes of early hospital discharge in patients with ST Elevation Myocardial Infarction after primary PCI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220809055645N5

Enrollment

228

Registered

2023-05-26

Start date

2023-06-05

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST elevation (STEMI) myocardial infarction. ST elevation (STEMI) myocardial infarction of unspecified site

Interventions

Intervention 1: Intervention group: They will be discharged from hospital within 48 hours. Intervention 2: Control group: According to conventional protocol, they will be discharged from the departmen

Eligibility

Sex/Gender

All

Age

No minimum to 75 Years

Inclusion criteria

Inclusion criteria: STEMI patients who undergo PCI primary with femoral access by an operator.

Exclusion criteria

Exclusion criteria: have had a life-threatening disease The left ventricular ejection fraction (LVEF) has been less than 30 percent. The patient's age is over 75 years old. The patient will have pulmonary edema ( Killip class II,III,IV) Each of the cases and criteria for occurrence of Major adverse cardiovascular events (MACE) included: acute myocardial infarction, acute coronary syndrome or ischemic heart disease (ACS/IHD), stroke (ischemic or hemorrhagic stroke), cardiovascular death (CV), and death by any cause. Patients who were readmitted. were not willing to continue to participate in the research. Perform Primary PCI with Radial Access were removed from the design.

Design outcomes

Primary

Measure	Time frame
Total deaths. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge.;Myocardial Infarction. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Stroke. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: CT_SCAN MRI.	—

Measure

Time frame

Total deaths. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge.;Myocardial Infarction. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Stroke. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: CT_SCAN MRI.

—

Secondary

Measure	Time frame
Readmission. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge.;Require Revocularization. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on patient reference records, in-person examination in weeks 2 and 6.;Recurrent chest pain. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge.;Arrhythmias. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Acute recurrent myocardial infarction. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Acute recurrent Coronary Syndrome. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Compliance to the drug. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report after discharge and during secondary referral to follow up the	—

Measure

Time frame

Readmission. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge.;Require Revocularization. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on patient reference records, in-person examination in weeks 2 and 6.;Recurrent chest pain. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge.;Arrhythmias. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Acute recurrent myocardial infarction. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Acute recurrent Coronary Syndrome. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state).;Compliance to the drug. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report after discharge and during secondary referral to follow up the

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Baharvand

Rasht University of Medical Sciences

dr.baharcardio@gmail.com+98 13 3366 4282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026